Jillian Dilmore serves as Executive at Baudax Bio, Inc., where they oversee executive responsibilities. Since joining the company, Jillian Dilmore has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 15, 2022 involved receiving (via award) 15,467 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 15, 2022 | BXRX | $0 | Award | 15,467 | $N/A | Discretionary |
Jillian Dilmore currently holds 15,738 shares of Baudax Bio, Inc. (BXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jillian Dilmore has been a net neutral trader of BXRX stock. They have purchased $0 and sold $0 worth of shares.
Jillian Dilmore's most recent insider trade was on Jun 15, 2022, when they sold 15,467 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted